Hu Y - Search Results

1

Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemia.

Dai Y, Huang J, Kuang P, Hu Y, Zeng Q, Zhang W, Li H, Wang F, Guo T, Zhang D, Yi D, Zheng Y, Liu T. Dai Y, et al. Among authors: hu y. Am J Cancer Res. 2022 Jun 15;12(6):2817-2832. eCollection 2022. Am J Cancer Res. 2022. PMID: 35812060 Free PMC article.

2

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia.

Yang L, Qiu Q, Tang M, Wang F, Yi Y, Yi D, Yang Z, Zhu Z, Zheng S, Yang J, Pei H, Zheng L, Chen Y, Gou L, Luo L, Deng X, Ye H, Hu Y, Niu T, Chen L. Yang L, et al. Among authors: hu y. Clin Cancer Res. 2019 Dec 15;25(24):7527-7539. doi: 10.1158/1078-0432.CCR-19-0516. Epub 2019 Aug 22. Clin Cancer Res. 2019. PMID: 31439580

3

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma.

Qiu Q, Li M, Yang L, Tang M, Zheng L, Wang F, Qiu H, Liang C, Li N, Yi D, Yi Y, Pan C, Yang S, Chen L, Hu Y. Qiu Q, et al. Among authors: hu y. Oncotarget. 2019 Oct 15;10(57):5993-6005. doi: 10.18632/oncotarget.27243. eCollection 2019 Oct 15. Oncotarget. 2019. PMID: 31666930 Free PMC article.

4

ALCAM-EGFR interaction regulates myelomagenesis.

Luo H, Zhang D, Wang F, Wang Q, Wu Y, Gou M, Hu Y, Zhang W, Huang J, Gong Y, Pan L, Li T, Zhao P, Zhang D, Qu Y, Liu Z, Jiang T, Dai Y, Guo T, Zhu J, Ye L, Zhang L, Liu W, Yi Q, Zheng Y. Luo H, et al. Among authors: hu y. Blood Adv. 2021 Dec 14;5(23):5269-5282. doi: 10.1182/bloodadvances.2021004695. Blood Adv. 2021. PMID: 34592762 Free PMC article.

5

Differential m⁶A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function.

Yin R, Chang J, Li Y, Gao Z, Qiu Q, Wang Q, Han G, Chai J, Feng M, Wang P, Zhang T, Xie X, Hu J, Cheng Y, Guo C, Wang J, Gao K, Cui M, Li S, Zheng Y, Jiang W, Hu Y, Yang QY, Zhang H. Yin R, et al. Among authors: hu j, hu y. Cell Stem Cell. 2022 Jan 6;29(1):149-159.e7. doi: 10.1016/j.stem.2021.09.014. Epub 2021 Oct 21. Cell Stem Cell. 2022. PMID: 34678169 Free article.

6

Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomide.

Santo L, Hideshima T, Cirstea D, Bandi M, Nelson EA, Gorgun G, Rodig S, Vallet S, Pozzi S, Patel K, Unitt C, Squires M, Hu Y, Chauhan D, Mahindra A, Munshi NC, Anderson KC, Raje N. Santo L, et al. Among authors: hu y. Clin Cancer Res. 2011 May 15;17(10):3259-71. doi: 10.1158/1078-0432.CCR-10-3012. Epub 2011 Mar 23. Clin Cancer Res. 2011. PMID: 21430070 Free PMC article.

7

TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN.

Qiu Q, Sun Y, Yang L, Li Q, Feng Y, Li M, Yin Y, Zheng L, Li N, Qiu H, Cui X, He W, Wang B, Pan C, Wang Z, Huang J, Sample KM, Li Z, Hu Y. Qiu Q, et al. Among authors: hu y. Signal Transduct Target Ther. 2023 Mar 1;8(1):90. doi: 10.1038/s41392-022-01290-7. Signal Transduct Target Ther. 2023. PMID: 36854750 Free PMC article.

8

CML Mouse Model Generated from Leukemia Stem Cells.

Hu Y. Hu Y. Methods Mol Biol. 2016;1465:27-35. doi: 10.1007/978-1-4939-4011-0_3. Methods Mol Biol. 2016. PMID: 27581136

9

Tmem30a Plays Critical Roles in Ensuring the Survival of Hematopoietic Cells and Leukemia Cells in Mice.

Li N, Yang Y, Liang C, Qiu Q, Pan C, Li M, Yang S, Chen L, Zhu X, Hu Y. Li N, et al. Among authors: hu y. Am J Pathol. 2018 Jun;188(6):1457-1468. doi: 10.1016/j.ajpath.2018.02.015. Epub 2018 Mar 21. Am J Pathol. 2018. PMID: 29574182 Free article.

10

SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules.

Wang F, Zheng L, Yi Y, Yang Z, Qiu Q, Wang X, Yan W, Bai P, Yang J, Li D, Pei H, Niu T, Ye H, Nie C, Hu Y, Yang S, Wei Y, Chen L. Wang F, et al. Among authors: hu y. Mol Cancer Ther. 2018 Apr;17(4):763-775. doi: 10.1158/1535-7163.MCT-17-0332. Mol Cancer Ther. 2018. PMID: 29610282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47,948 results

Search Page

Filters